No. of Pages: 118 | Report Code: TIPRE00020137 | Category: Life Sciences
真菌の全身感染症は、免疫抑制や後天性免疫不全症候群 (AIDS) 患者など、免疫力が低下している患者によく見られます。全身症状としては、無呼吸、グアヤック陽性便、腹部膨満、高血糖、白血病反応、低血圧などが統合されます。全身性カンジダ症およびアスペルギルス症の治療には非経口抗真菌療法が必要であり、この状態は高い死亡率と関連しています。さらに、この感染症は、長期生存者に永続的な神経発達障害を引き起こす可能性があります。
南部中米の全身性アスペルギルス症および全身性カンジダ症市場は、2019年の3億809万米ドルから2027年までに3億9,506万米ドルに達すると予測されています。 2020 年から 2027 年までに 3.2% の CAGR で成長すると推定されています。中南米の全身性アスペルギルス症および全身性カンジダ症市場の成長は、真菌性疾患の有病率の上昇、院内感染の真菌感染症の増加に起因すると考えられています。しかし、抗真菌薬に対する耐性の増加、抗真菌薬の副作用により、この地域の市場の成長は制限されています。中南米の国々は、新型コロナウイルス感染症の拡大により、大きな困難に直面すると予想されています。病気の発生により、ヘルスケア業界は悪影響を受け、製品の発売や製品プロモーションカンファレンスなどの多くのビジネス関連活動が延期され、市場の成長が抑制されています。
中南米の全身性アスペルギルス症および全身性カンジダ症市場は、種類に基づいて、ボリコナゾール、リポソーム、アムホテリシン b、全身性経口アゾール、局所用に分類されます。 、抗真菌剤など。 2019年には、全身性経口アゾールセグメントが市場でより大きなシェアを占めました。また、予測期間中にはより速いペースで成長すると予想されます。
中南米の全身性アスペルギルス症および全身性カンジダ症市場レポートを作成する際に参照されるいくつかの主要な一次および二次情報源は、世界保健機関、保健予防省、および保健家族福祉省です。
Novartis AG、Sanofi、Pfizer Inc.、Merck and Co., Inc.、Bayer AG、アステラス製薬 Inc.、GlaxoSmithKline plc.、Abbott、Cipla Inc.
< /span>
タイプ別
用途別
Strategic insights for South and Central America Systemic Aspergillosis and Systemic Candidasis involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 308.09 Million |
| Market Size by 2027 | US$ 395.06 Million |
| Global CAGR (2020 - 2027) | 3.2% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By タイプ
|
| Regions and Countries Covered | 南米および中米
|
| Market leaders and key company profiles |
The regional scope of South and Central America Systemic Aspergillosis and Systemic Candidasis refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Systemic Aspergillosis and Systemic Candidasis Market is valued at US$ 308.09 Million in 2019, it is projected to reach US$ 395.06 Million by 2027.
As per our report South and Central America Systemic Aspergillosis and Systemic Candidasis Market, the market size is valued at US$ 308.09 Million in 2019, projecting it to reach US$ 395.06 Million by 2027. This translates to a CAGR of approximately 3.2% during the forecast period.
The South and Central America Systemic Aspergillosis and Systemic Candidasis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Systemic Aspergillosis and Systemic Candidasis Market report:
The South and Central America Systemic Aspergillosis and Systemic Candidasis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Systemic Aspergillosis and Systemic Candidasis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Systemic Aspergillosis and Systemic Candidasis Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America Systemic Aspergillosis and Systemic Candidasis Market
